Page 2 - Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 17, 2025

Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

761 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
TEVA Teva Pharmaceutical Industries	US$13.65	6.5%	6.8%	US$15.4b	US$22.88	PB2.9x	E67.4%	0%
WST West Pharmaceutical Services	US$201.90	-0.9%	-46.5%	US$15.1b	US$284.51	PE29.6x	E9.2%	0.4%
INSM Insmed	US$72.65	6.0%	198.7%	US$13.1b	US$97.24	PS36.2x	E57.1%	n/a
UTHR United Therapeutics	US$284.73	2.1%	20.2%	US$12.8b	US$394.93	PE10.7x	E8.0%	n/a
ICLR ICON	US$139.32	-2.3%	-52.3%	US$11.6b	US$213.63	PE14.2x	E8.6%	n/a
BMRN BioMarin Pharmaceutical	US$59.17	5.1%	-34.3%	US$11.3b	US$96.87	PE26.6x	E20.2%	n/a
ILMN Illumina	US$71.20	-4.8%	-39.4%	US$11.3b	US$120.12	PS2.6x	E51.6%	4.4%
RVTY Revvity	US$91.82	-1.3%	-7.6%	US$11.3b	US$132.55	PE39x	E20.1%	0.3%
INCY Incyte	US$58.21	5.5%	10.2%	US$11.2b	US$73.40	PE345.4x	E23.4%	n/a
AVTR Avantor	US$15.10	2.7%	-37.9%	US$10.4b	US$22.51	PE14.5x	E-1.7%	n/a
EXEL Exelixis	US$36.19	5.0%	60.9%	US$10.1b	US$37.95	PE19.4x	E22.5%	n/a
NBIX Neurocrine Biosciences	US$101.38	11.8%	-23.5%	US$10.0b	US$158.26	PE29.6x	E26.3%	n/a
MRNA Moderna	US$24.72	-5.7%	-75.6%	US$9.6b	US$51.14	PS3x	E28.5%	n/a
ASND Ascendis Pharma	US$165.05	15.2%	17.1%	US$9.5b	US$215.61	PS23.9x	E59.7%	n/a
MEDP Medpace Holdings	US$296.28	4.9%	-20.8%	US$9.0b	US$332.66	PE22.3x	E7.5%	n/a
QGEN Qiagen	US$40.71	1.6%	0.3%	US$9.0b	US$49.23	PE105.3x	E26.3%	3.1%
VTRS Viatris	US$7.56	4.1%	-32.0%	US$8.8b	US$12.03	PB0.5x	E81.7%	6.3%
TECH Bio-Techne	US$48.10	-2.4%	-22.7%	US$7.9b	US$79.70	PE48.1x	E22.3%	0.7%
EXAS Exact Sciences	US$41.58	-4.9%	-34.5%	US$7.9b	US$66.89	PS2.8x	E86.8%	n/a
RGEN Repligen	US$130.00	12.9%	-17.2%	US$7.4b	US$187.60	PS11.5x	E42.1%	n/a
HALO Halozyme Therapeutics	US$58.79	1.9%	55.5%	US$7.3b	US$68.13	PE16.4x	E14.8%	n/a
ROIV Roivant Sciences	US$10.15	5.2%	-2.0%	US$7.1b	US$16.00	PS59.1x	E21.3%	n/a
TEM Tempus AI	US$40.45	0.4%	n/a	US$7.1b	US$61.56	PS10.1x	E54.2%	n/a
CORT Corcept Therapeutics	US$62.24	-8.1%	174.7%	US$6.8b	US$143.25	PE47x	E39.0%	n/a

Page 2 of 32